ScoreWhy is Shanghai Rendu Biotechnology Co., Ltd. ?
1
The company has declared Positive results for the last 4 consecutive quarters
- INVENTORY TURNOVER RATIO(HY) Highest at 2.14 times
- NET PROFIT(Q) Highest at CNY 6.06 MM
- RAW MATERIAL COST(Y) Fallen by -1.68% (YoY)
2
With ROE of 1.33%, it has a attractive valuation with a 2.33 Price to Book Value
- Over the past year, while the stock has generated a return of 4.99%, its profits have risen by 221.6% ; the PEG ratio of the company is 0.8
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Shanghai Rendu Biotechnology Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shanghai Rendu Biotechnology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shanghai Rendu Biotechnology Co., Ltd.
4.42%
1.71
42.14%
China Shanghai Composite
0.9%
0.22
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-14.01%
EBIT Growth (5y)
-148.12%
EBIT to Interest (avg)
-6.09
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.84
Sales to Capital Employed (avg)
0.18
Tax Ratio
8.41%
Dividend Payout Ratio
441.63%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.64%
ROE (avg)
2.04%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
176
Industry P/E
Price to Book Value
2.33
EV to EBIT
-428.24
EV to EBITDA
121.70
EV to Capital Employed
10.13
EV to Sales
8.27
PEG Ratio
0.79
Dividend Yield
NA
ROCE (Latest)
-2.37%
ROE (Latest)
1.32%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend19What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 2.14 times
NET PROFIT(Q)
Highest at CNY 6.06 MM
RAW MATERIAL COST(Y)
Fallen by -1.68% (YoY
PRE-TAX PROFIT(Q)
Highest at CNY 6.42 MM
-2What is not working for the Company
NET SALES(Q)
Lowest at CNY 37.36 MM
Here's what is working for Shanghai Rendu Biotechnology Co., Ltd.
Net Profit
Highest at CNY 6.06 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Inventory Turnover Ratio
Highest at 2.14 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Pre-Tax Profit
Highest at CNY 6.42 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Pre-Tax Profit
At CNY 6.42 MM has Grown at 99.53%
over average net sales of the previous four periods of CNY 3.22 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 6.06 MM has Grown at 99.01%
over average net sales of the previous four periods of CNY 3.04 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Raw Material Cost
Fallen by -1.68% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shanghai Rendu Biotechnology Co., Ltd.
Net Sales
Lowest at CNY 37.36 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Net Sales
At CNY 37.36 MM has Fallen at -8.51%
over average net sales of the previous four periods of CNY 40.83 MMMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Footer loading
